Business
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the
About this update from Staar Surgical Company
[{"type":"text","content":" LAKE FOREST, Calif.--(BUSINESS WIRE)--\nSTAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31, 2022, after leading the company through a significant period of revitalization and growth for more than seven years. STAAR’s Board of Directors has appointed ophthalmic industry executive Thomas “Tom” G. Frinzi, current Board Chair of STAAR, to serve as President and CEO, effective January 1, 2023.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221219005204/en/Ophthalmic industry executive Tom Frinzi has been appointed President & CEO of STAAR Surgical, effective January 1, 2023. (Photo: Business Wire)\nTo ensure a seamless transition, Ms. Mason has agreed to serve in an advisory role through December 31, 2023.\n\n\"On behalf of the entire Board, I want to thank Caren for her exceptional tenure as STAAR’s President and CEO since March 2015,” said Aimee S. Weisner, Chair of the Board’s Nominating and Governance Committee. “Under Caren’s leadership, STAAR has achieved numerous significant milestones including accelerating average revenue growth above 25% over the past several years and gaining U.S. FDA approval of our EVO lenses earlier this year. At the same time, Caren has overseen a dramatic increase in shareholder value with shares of STAAR increasing in value by almost 10 times during her tenure. She leaves STAAR in an incredibly strong financial and market position.”\n\nMs. Mason was appointed President and Chief Executive Officer of STAAR in March 2015 after serving as an independent Director on STAAR’s Board of Directors since 2014. Prior to joining STAAR, Ms. Mason served as CEO and in other senior executive roles at numerous innovative healthcare, life sciences, diagnostic technology, and medical device companies.\n\n“Serving as CEO of STAAR Surgical has been the highlight of my career,” said Ms. Mason. “I am proud of STAAR’s accomplishments under my leadership over the past seven years, and I am grateful for the many dedicated professionals around the world who make STAAR such a phenomenal company. I look forward to watching STAAR’s continued success and have great confidence in Tom and the amazing S...